In order to define possible mechanisms of immunomodulation by glatiramer ac
etate (GA), we investigated the primary in vitro cytokine response of perip
heral blood mononuclear cells (PBMCs) and T-cell subpopulations. In PBMCs f
rom healthy subjects and untreated patients with multiple sclerosis (MS) GA
-induced T-cell proliferation and mRNA expression/cytokine. secretion of IL
-13 and IL-5 but not of IL-10. TGF-beta or IL-12, IL-4 was detected at the
mRNA level only. IFN-gamma was induced in a few subjects at very low concen
trations. The response to GA was driven by the CD4(+)/CD45RA(+) T-cell subp
opulation and was mediated by T-cell receptor (TCR) engagement as determine
d by anti-TCR blocking antibodies, The findings are compatible with the hyp
othesis that GA functions as partial or weak TCR-agonist activating naive T
cells to produce the Th2 cytokines IL-13 and IL-5. (C) 2001 Elsevier Scien
ce B.V. All rights reserved.